These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-002015-86 Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Scalp Psoriasis. 2005-09-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-002152-33 Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle and Calcipotriol in the Gel Vehicle in Scalp Psoriasis. A phase III study comparing a gel con... 2015-07-12 bad-data
Reported results 2004-002687-14 Fucidin® Cream in the Treatment of Impetigo A phase IV study comparing clinical and bacteriological efficacy of Fucidin® cream with Fucidin® cream vehicle in the treatment of impetigo in paediatric pa... 2005-03-11 due-trials
Reported results 2004-002861-19 Long-term treatment of Scalp Psoriasis with Calciptriol plus Betamethasone dipropionate gel. A phase III safety study of a new gel containing calcipotriol 50mcg/g plus betamethasone 0.5 mg/g (as dipro... 2006-09-22 due-trials
Reported results 2004-004577-28 Different treatment regimens of calcipotriol cream and combination (calcipotiol/betamethasone dipropionate) ointment in psoriasis vulgaris 2005-12-13 due-trials
Reported results 2005-002270-29 Safety profile of innohep versus subcutaneous unfractionated Heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis 2008-05-26 due-trials
Reported results 2005-002864-27 Calcipotriol plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients with Scalp Psoriasis. A phase III study comparing a gel containing calcipotriol 50 mcg/g plus b... 2006-05-17 due-trials
Reported results 2005-003215-78 Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Psoriasis Vulgaris. 2006-05-08 due-trials
Reported results 2006-001472-20 LEO19123 Cream in the Treatment of Atopic Dermatitis A Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatment... 2007-08-24 due-trials
Reported results 2006-002686-39 LEO19123 Cream in the Treatment of Hand Eczema A Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatment of ha... 2007-07-11 due-trials
Reported results 2006-002873-35 Exploratory efficacy and safety, pharmacokinetics and dose-finding study of ATryn® (antithrombin alfa) in patients with disseminated intravascular coagulation associated with severe sepsis 2009-03-18 due-trials
Reported results 2007-003365-41 Calcipotriol Plus Hydrocortisone Ointment Compared with Tacalcitol Ointment in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas. A phase 3 study comparing an ointment conta... 2009-06-18 due-trials
Reported results 2007-004782-18 Calcipotriol Plus Hydrocortisone in Psoriasis Vulgaris on the Face and on the Intertriginous Areas. A phase 3 study comparing an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g ... 2010-11-11 due-trials
Ongoing, reported early 2007-005463-10 A plaque test comparing three marketed products and two products in development and a vehicle control for the treatment of psoriasis vulgaris not-yet-due
Reported results 2007-005501-22 Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Patients with Psoriasis Vulgaris on the Face and on the Intertriginous Areas 2009-12-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005456-24 Safety and Efficacy of Calcipotriol plus Betamethasone Dipropionate Gel in Adolescent Patients (Aged 12 to 17 Years) with Scalp Psoriasis 2012-10-15 bad-data
Ongoing, reported early 2008-005487-13 A plaque test comparing 4 steroids with Daivobet® ointment and a vehicle control for the treatment of psoriasis vulgaris not-yet-due
Reported results 2009-010963-18 A phase 3 study comparing an ointment containing calcipotriol 25 mcg/g plus hydrocortisone 10 mg/g (LEO 80190 ointment) with hydrocortisone 10 mg/g ointment, both applied once daily in the treatment o... 2010-06-08 due-trials
Reported results 2009-013792-22 A Phase 2, proof of concept and dose finding study, investigating treatment efficacy of LEO 29102 cream (2.5 mg/g, 1.0 mg/g, 0.3 mg/g, 0.1 mg/g, 0.03 mg/g), LEO 29102 cream vehicle, and Elidel (Pimecr... 2010-06-30 due-trials
Ongoing, reported early 2009-017858-12 A phase 2a proof of concept study comparing three doses of an oral solution of LEO 22811 with a placebo oral solution for the treatment of psoriasis vulgaris not-yet-due
Reported results 2009-018141-20 A Phase 3 Study of Subcutaneous Innohep 20,000 anti-Xa IU/ml for the Treatment of Venous Thromboembolism (VTE) in Cancer Patients 2014-06-25 due-trials
Completed, but no date Terminated 2010-021941-38 LEO 90110 ointment in the treatment of psoriasis vulgaris bad-data
Reported results 2011-005018-13 Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp 2014-02-04 due-trials
Reported results Terminated 2011-006275-20 A phase II exploratory study evaluating the efficacy of topical cromoglicate solution(20mg/ml) compared to topical solution vehicle in the treatment of mastocytosis 2013-03-05 due-trials
Reported results 2012-000253-30 An exploratory study evaluating the efficacy of cromoglicate cream compared to cream vehicle in the treatment of itch in psoriasis Eine explorative Studie, die die Wirksamkeit einer Cromoglicat-Cre... 2013-04-11 due-trials
Reported results 2012-002863-88 A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen with Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas with Actinic Keratosis on Face/Scalp and Trunk/Extremities Un reg... 2014-01-22 due-trials
Reported results 2012-003112-31 Risk of Squamous Cell Carcinoma on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% 2019-07-11 due-trials
Reported results 2013-000410-38 Topical Aprepitant in Prurigo Patients (iTAPP) An exploratory phase IIa trial with topically applied aprepitant in patients with prurigo Topisches Aprepitant bei Patienten mit Prurigo (iTAPP) Ein... 2014-07-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-001538-16 Effect of Calcipotriol plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 months) with Scalp and Body Psoriasis 2018-02-13 bad-data
Ongoing, reported early 2013-004686-14 LEO 90100 aerosol foam compared to calcipotriol plus betamethasone dipropionate gel in subjects with psoriasis vulgaris not-yet-due
Reported results 2014-000037-23 Clinical Study Protocol Safety and efficacy of escalating doses of LEO 43204 applied once daily for two consecutive days on full balding scalp in subjects with actinic keratosis Part 1: A phase 1, m... 2015-03-06 due-trials
Reported results 2014-003072-24 Patient insights following use of LEO 90100 aerosol foam and Daivobet® gel in subjects with psoriasis vulgaris 2015-11-30 due-trials
Reported results 2014-003218-98 Efficacy and safety of ingenol mebutate gel 0.015% compared to diclofenac sodium gel 3% in subjects with actinic keratoses on the face or scalp. 2016-07-13 due-trials
Reported results 2014-004465-24 Safety and efficacy of repeat use of Picato® 0.05% in the treatment of anogenital warts 2015-11-26 due-trials
Ongoing, reported early 2014-004759-30 A psoriasis plaque test trial with LP0113 spray in patients with psoriasis vulgaris not-yet-due
Reported results 2015-000839-33 Safety and Effect of LEO 90100 aerosol foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) with Plaque Psoriasis A phase 2 trial evaluating the safety and effic... 2018-03-28 due-trials
Ongoing, reported early 2015-001798-41 A psoriasis plaque test trial with LEO 90100 compared to Betesil® in patients with psoriasis vulgaris not-yet-due
Reported results 2015-002098-40 A Phase 2a, Proof of Concept Trial, testing twice daily application of LEO 124249 ointment 30mg/g in the treatment of mild to moderate inverse psoriasis 2016-09-19 due-trials
Reported results 2015-002449-71 Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2: exte... 2017-11-14 due-trials
Reported results 2015-002450-12 Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2: exte... 2017-08-10 due-trials
Reported results 2015-002451-10 Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2: exten... 2017-09-06 due-trials
Reported results 2015-002452-27 Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2: exte... 2017-10-27 due-trials
Reported results 2015-005279-25 LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris A phase 2a proof of concept study comparing an oral tablet formulation of LEO 32731 with a corresponding placebo tablet in patients... 2017-07-06 due-trials
Reported results 2016-000556-95 LEO 90100 twice weekly maintenance regimen for psoriasis vulgaris 2019-07-02 due-trials
Reported results 2016-003867-21 A phase 4 trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate to severe plaque psoriasis 2019-05-02 due-trials
Reported results 2016-004200-65 A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab monotherapy in subjects with moderate to severe atopic dermatitis who are candidates f... 2019-10-10 due-trials
Reported results 2016-004201-13 A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab monotherapy in subjects with moderate to severe atopic dermatitis who are candidates f... 2019-08-15 due-trials
Reported results Terminated 2017-000228-85 Incidence of squamous cell carcinoma and other skin neoplasia in subjects with actinic keratosis treated with ingenol disoxate gel 0.018% or 0.037%, or vehicle A phase 3 trial to compare the incidenc... 2018-03-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2017-002065-21 A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroid in subjects with moderate-to-severe atopic ... 2019-09-26 bad-data
Reported results Terminated 2017-002720-24 Efficacy of twice daily application of LEO 124249 ointment 30 mg/g for 12 weeks on eyebrow alopecia areata. Exploratory Phase 2a 2018-05-16 due-trials
Reported results Terminated 2017-004508-23 Capture of LEO 90100 medication usage with digital tracker and evaluation of efficacy in patients with psoriasis 2018-06-11 due-trials
Other 2017-004998-13 Adjustable brodalumab dosage regimen compared with standard brodalumab treatment for 52 weeks in subjects with moderate-to-severe plaque psoriasis and =120 kg body weight Regime di dosaggio di brod... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2017-005143-33 A randomised, double-blind, placebo-controlled, parallel-group, multi-centre trial to evaluate the efficacy, safety, and tolerability of tralokinumab monotherapy in adolescent subjects with moderate-t... 2021-03-16 bad-data
Other 2018-000746-19 An open-label, single-arm, multi-centre, long-term extension trial to evaluate the safety and efficacy of tralokinumab in subjects with atopic dermatitis who participated in previous tralokinumab clin... not-yet-due
Listed as ongoing, but also has a completion date 2018-000747-76 A randomised, double-blind, placebo-controlled, parallel-group, multi-centre, phase 3 trial investigating the efficacy, safety, and tolerability of tralokinumab administered in combination with topica... 2020-09-28 bad-data
Reported results 2018-000900-40 A phase 2b, double-blind, randomised, 5-arm, vehicle-controlled, dose-ranging trial to evaluate the efficacy and safety of twice daily topical application of delgocitinib cream 1, 3, 8, and 20 mg/g fo... 2020-04-20 due-trials
Reported results Terminated 2018-003615-22 Efficacy and safety of twice-daily application of delgocitinib cream 20 mg/g for 6 weeks in subjects with active discoid lupus erythematosus. A phase 2a exploratory, randomised, double-blind, vehicle-... 2020-05-07 due-trials
Other 2019-001868-30 A phase 3, randomised, double-blind, multi-centre trial to evaluate the efficacy, safety, and tolerability of brodalumab treatment compared to placebo (blinded) and ustekinumab (open-label) in adolesc... not-yet-due
Other 2019-004099-20 Efficacy and safety comparison of brodalumab versus guselkumab in adult subjects with moderate-to-severe plaque psoriasis and inadequate response to ustekinumab. not-yet-due
Ongoing 2020-002960-30 A phase 3 clinical trial to confirm efficacy and evaluate safety of twice-daily delgocitinib cream 20 mg/g compared with cream vehicle for a 16-week treatment period in adult subjects with moderate to... not-yet-due
Ongoing 2020-002961-32 A phase 3 clinical trial to confirm efficacy and evaluate safety of twice-daily delgocitinib cream 20 mg/g compared with cream vehicle for a 16-week treatment period in adult subjects with moderate to... not-yet-due
Ongoing 2020-002962-15 A phase 3 extension trial of DELTA 1 and DELTA 2 to evaluate the long-term safety of a twice-daily treatment with delgocitinib cream 20 mg/g as needed for up to 36 weeks in adult subjects with chronic... not-yet-due
Ongoing 2020-004561-39 A phase 2 trial to evaluate the efficacy and safety of orally administered LEO 152020 tablets compared with placebo tablets for up to 16 weeks of treatment in adults with moderate to severe atopic der... not-yet-due
Ongoing 2020-004961-38 Phase 2a trial to assess the efficacy and safety of LEO 152020 in adult patients with cholinergic urticaria Phase 2a Studie zur Beurteilung der Wirksamkeit und Sicherheit von LEO 152020 bei erwachs... not-yet-due
Ongoing 2020-005541-16 A phase 2a, randomised, double-blind, placebo-controlled, multi-site, proof of concept trial to evaluate the efficacy and safety of LEO 138559 in adult subjects with moderate to severe atopic dermatit... not-yet-due
Trial is outside EEC 2021-000404-37 A phase 1 open-label, multi-centre, single-arm trial to evaluate the safety and pharmacokinetics (including MUsT) of twice daily topical application of delgocitinib cream for 8 weeks in adults, adoles... bad-data